Similar articles

• Treating antidepressant nonresponders with augmentation strategies: an overview.

  Thase ME, Howland RH, Friedman ES. Thase ME, et al. J Clin Psychiatry. 1998;59 Suppl 5:5-12; discussion 13-5. J Clin Psychiatry. 1998. PMID: 9635543 Review.
• Antidepressant augmentation: conclusions and recommendations.

  Sussman N, Joffe RT. Sussman N, et al. J Clin Psychiatry. 1998;59 Suppl 5:70-3. J Clin Psychiatry. 1998. PMID: 9635551 No abstract available.
• Potentiation strategies for treatment-resistant depression.

  Ros S, Agüera L, de la Gándara J, Rojo JE, de Pedro JM. Ros S, et al. Acta Psychiatr Scand Suppl. 2005;(428):14-24, 36. doi: 10.1111/j.1600-0447.2005.00676.x. Acta Psychiatr Scand Suppl. 2005. PMID: 16307616 Review.
• Augmentation strategies for treatment-resistant depression: a literature review.

  Carvalho AF, Cavalcante JL, Castelo MS, Lima MC. Carvalho AF, et al. J Clin Pharm Ther. 2007 Oct;32(5):415-28. doi: 10.1111/j.1365-2710.2007.00846.x. J Clin Pharm Ther. 2007. PMID: 17875106 Review.
• The use of thyroid supplements to augment antidepressant medication.

  Joffe RT. Joffe RT. J Clin Psychiatry. 1998;59 Suppl 5:26-9; discussion 30-1. J Clin Psychiatry. 1998. PMID: 9635545 Review.